Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02923466
Recruitment Status : Active, not recruiting
First Posted : October 4, 2016
Last Update Posted : July 7, 2021
Information provided by (Responsible Party):
Vyriad, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : December 2022